[HTML][HTML] Targeting myeloperoxidase (MPO) mediated oxidative stress and inflammation for reducing brain ischemia injury: Potential application of natural compounds
Oxidative stress and inflammation are two critical pathological processes of cerebral
ischemia-reperfusion injury. Myeloperoxidase (MPO) is a critical inflammatory enzyme and …
ischemia-reperfusion injury. Myeloperoxidase (MPO) is a critical inflammatory enzyme and …
[HTML][HTML] Oxidative stress and the use of antioxidants in stroke
R Shirley, ENJ Ord, LM Work - Antioxidants, 2014 - mdpi.com
Transient or permanent interruption of cerebral blood flow by occlusion of a cerebral artery
gives rise to an ischaemic stroke leading to irreversible damage or dysfunction to the cells …
gives rise to an ischaemic stroke leading to irreversible damage or dysfunction to the cells …
Pathogenesis of acute stroke and the role of inflammasomes
Inflammation is an innate immune response to infection or tissue damage that is designed to
limit harm to the host, but contributes significantly to ischemic brain injury following stroke …
limit harm to the host, but contributes significantly to ischemic brain injury following stroke …
[HTML][HTML] The neuroprotection of liraglutide against ischaemia-induced apoptosis through the activation of the PI3K/AKT and MAPK pathways
H Zhu, Y Zhang, Z Shi, D Lu, T Li, Y Ding, Y Ruan… - Scientific reports, 2016 - nature.com
Abstract Glucagon-like peptide-1 (GLP-1) is an incretin hormone that increases glucose-
dependent insulin secretion to reduce the glucose level. Liraglutide, a long-acting GLP-1 …
dependent insulin secretion to reduce the glucose level. Liraglutide, a long-acting GLP-1 …
[HTML][HTML] Neuroprotection for stroke: current status and future perspectives
J Minnerup, BA Sutherland, AM Buchan… - International journal of …, 2012 - mdpi.com
Neuroprotection aims to prevent salvageable neurons from dying. Despite showing efficacy
in experimental stroke studies, the concept of neuroprotection has failed in clinical trials …
in experimental stroke studies, the concept of neuroprotection has failed in clinical trials …
[HTML][HTML] Oxidative stress and cerebral endothelial cells: regulation of the blood–brain-barrier and antioxidant based interventions
LR Freeman, JN Keller - Biochimica et Biophysica Acta (BBA)-Molecular …, 2012 - Elsevier
While numerous lines of evidence point to increased levels of oxidative stress playing a
causal role in a number of neurodegenerative conditions, our current understanding of the …
causal role in a number of neurodegenerative conditions, our current understanding of the …
[HTML][HTML] Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury
Ischemic stroke accounts for nearly 80% of stroke cases. Recanalization with thrombolysis is
a currently crucial therapeutic strategy for re-building blood supply, but the thrombolytic …
a currently crucial therapeutic strategy for re-building blood supply, but the thrombolytic …
Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia
G Mifsud, C Zammit, R Muscat… - CNS neuroscience & …, 2014 - Wiley Online Library
Oligodendrocytes (OL s), the myelin‐forming cells of the central nervous system, form a
functional unit with axons and play a crucial role in axonal integrity. An episode of hypoxia …
functional unit with axons and play a crucial role in axonal integrity. An episode of hypoxia …
[HTML][HTML] Physical activity vs. redox balance in the brain: brain health, aging and diseases
P Sutkowy, A Woźniak, C Mila-Kierzenkowska… - Antioxidants, 2021 - mdpi.com
It has been proven that physical exercise improves cognitive function and memory, has an
analgesic and antidepressant effect, and delays the aging of the brain and the development …
analgesic and antidepressant effect, and delays the aging of the brain and the development …
Drug therapy in stroke: from preclinical to clinical studies
Background: Stroke is one of the major challenges to health and the reason for increasing
disability-adjusted life years. Despite tremendous progress in preclinical studies, none of the …
disability-adjusted life years. Despite tremendous progress in preclinical studies, none of the …